SurgePays Stock: Reasons Behind the Latest Rating Downgrade and Earnings Miss in FY2023

Tuesday, 26 March 2024, 08:38

SurgePays disappointed investors with a significant revenue and earnings miss in FY2023, leading to a rating downgrade. The post discusses the reasons behind the underperformance and sheds light on the implications for investors. It also highlights why a previous Buy rating on SURG stock may not have been a wise decision.
https://store.livarava.com/24f5617f-eb4d-11ee-aebb-63fd8ea994ba.jpg
SurgePays Stock: Reasons Behind the Latest Rating Downgrade and Earnings Miss in FY2023

SurgePays Stock: Reasons Behind the Latest Rating Downgrade and Earnings Miss in FY2023

SurgePays missed massively on revenue and earnings consensus estimates in FY2023. Read why my previous Buy rating on SURG stock didn't age well.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Do you want to advertise here?

Related posts


Do you want to advertise here?
Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe